All posts

Buy Amazon stock on pullbacks in 2019, says this investor

Brian Acker
If you’re not into retail arbitrage, at least there’s money to be made on owning Amazon stock (Amazon Stock Quote, Chart NASDAQ:AMZN), says Brian Acker of Acker Finley, who argues that patient investors should be waiting for another pullback.

AMZN seemed like an unstoppable force over the past few years, pushing up from the $600 range back in early 2016 to flirting with $2,000 by mid-2018. (All figures in US dollars.) Then came the great tech selloff starting in early fall which saw most of the well-known names take major hits, including Amazon which dropped 33 per cent between October 1 and December 24.

A January rally helped somewhat but the market seems less confident about stocks like Amazon than it has in the past, says Acker, CEO and chief investment strategist at Acker Finley.

“As a straightforward investment, I would love to see this pull back to $1369.00. With all of the stocks that I love and I look for, I always want that pullback and certainly I think that this year and in this market, you’re going to get lots of pullbacks,” says Acker, in conversation with BNN Bloomberg on Friday.

“It was actually down close to there at the end of December. Hopefully, it now comes back,” he says.

Amazon’s share price took a hit after the company issued its latest quarterly report on January 31, beating consensus estimates on both earnings and revenue yet causing investors concern with its first quarter guidance which stated that revenue should come in between $56 billion and $60 billion, below the consensus expectation of $60.8 billion. The company said that it expected a period of increased spending across hiring and capital expenditures during 2019, following on a period of slower investment in 2018.

Disclosure: Cantech Letter editor Nick Waddell owns shares of Amazon

Tagged with: amzn
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Constellation Software could be the best compounder ever, this fund manager says

Raymond James Investment Council portfolio manager Chris Blumas said on BNN Bloomberg’s Market Call on Oct. 15 that he continues… [Read More]

5 minutes ago

Is Shopify worth its pricey valuation?

RBC Dominion Securities analyst Paul Treiber maintained an “Outperform” rating and raised his price target on Shopify  (Shopify Stock Quote,… [Read More]

22 hours ago

Canadians are still spending, RBC economists note

RBC economists Abbey Xu and Rachel Battaglia said in an Oct. 16 report that Canadian cardholder spending remained strong in… [Read More]

22 hours ago

Amazon could be a “significant” AI winner, this analyst says

Roth Capital Markets analyst Rohit Kulkarni maintained a “Buy” rating and US$250.00 12-month target on Amazon (Amazon Stock Quote, Chart,… [Read More]

22 hours ago

This analyst just raised his price target on Cingulate

Roth Capital Markets analyst Boobalan Pachaiyappan raised his target price on Cingulate (Cingulate Stock Quote, Chart, News, Analysts, Financials NASDAQ:CING)… [Read More]

23 hours ago

D-Wave just won a huge price target raise from this analyst

Roth Capital Markets analyst Suji Desilva raised his price target on D-Wave Quantum (D-Wave Stock Quote, Chart, News, Analysts, Financials… [Read More]

2 days ago